Debt to Equity Ratio Chart

View Debt to Equity Ratio for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.8032
March 31, 2026 0.7452
December 31, 2025 0.4437
September 30, 2025 0.4493
June 30, 2025 0.2637
March 31, 2025 0.2022
December 31, 2024 0.1767
September 30, 2024 0.841
June 30, 2024 0.5092
March 31, 2024 0.329
December 31, 2023 0.2745
September 30, 2023 0.3787
June 30, 2023 0.323
March 31, 2023 0.2952
December 31, 2022 0.2667
September 30, 2022 0.2461
June 30, 2022 0.2242
March 31, 2022 0.4406
Date Value
December 31, 2021 0.4478
September 30, 2021 0.2869
June 30, 2021 0.2556
March 31, 2021 0.2318
December 31, 2020 0.2191
September 30, 2020 0.5224
June 30, 2020 0.058
March 31, 2020 0.051
December 31, 2019 0.047
September 30, 2019 0.0457
June 30, 2019 0.0443
March 31, 2019 0.0639
December 31, 2018 0.0043
September 30, 2018 0.0061
June 30, 2018 0.0065
March 31, 2018 0.0187
December 31, 2017 0.0187

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agenus, Inc. -1.458
Amgen, Inc. 4.903
Anika Therapeutics, Inc. 0.1839
BioCryst Pharmaceuticals, Inc. -1.842
Imunon, Inc. 1.873

Debt to Equity Ratio Related Metrics